FBLG
FibroBiologics, Inc. Common Stock
NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY
$1.32
+0.76% today
Updated 2026-04-30
Market cap
$6.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$1 – $23
Volume
1.0M
FibroBiologics, Inc. Common Stock (FBLG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $-1.17M | $-1.41M | $-4.07M | $-6.40M | $-11.90M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $495000.00 | $184000.00 |
| Depreciation | — | — | — | — | — |
| Stock-based comp | — | $0.00 | $265000.00 | $1.76M | $2.22M |
| Free cash flow | $-1.17M | $-1.41M | $-4.07M | $-6.90M | $-12.09M |
| Investing cash flow | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — |
| Dividends paid | — | — | — | — | — |
| Share repurchases | — | — | — | — | — |
| Debt repayment | — | — | — | — | — |
| Net change in cash | — | — | — | — | — |